Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help raise money and awareness for men's health issues like mental health and suicide prevention, testicular cancer and prostate cancer.

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2, and PALB2.

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, killing cancer cells and enhancing the effects of drugs like enzalutamide.

Despite global campaigns, awareness of prostate and testicular cancer remains low in India. Experts explain why and what can help encourage timely screening

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven effectiveness in extending survival.

John Tesh is opening up about his battle with cancer — and how his wife, Connie Sellecca, helped save his life by ensuring he got the proper care.